What are epidermal growth factor receptor (EGFR) mutations? Learn more about their biology, formation, and impact on lung cancer.
This subtype occurs in 10% to 15% of cases and is more common in people who have never smoked.
Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.
Asking the right questions about your EGFR-positive non-small-cell lung cancer will help you find the best treatment for you.
Depending on the stage and specific mutation of this lung cancer, there are several treatment options and “lots of hope,” says oncologist Susan Scott, MD.
Some non-small-cell lung cancers (NSCLC) have changes in a gene called EGFR. If your NSCLC has these mutations, your doctor likely will recommend treatment with targeted therapies that block EGFR. Learn what you should know about your treatment options and outlook.
Who’s most at risk for getting EGFR-positive lung cancer? Learn which factors increase your chances.
You’ll have more treatment options for EGFR-positive non-small-cell lung cancer (NSCLC) now than ever before. But doctors are still testing new treatments and combinations in clinical trials. Find out if a clinical trial may be an option for you.
